DELGOCITINIB

DELGOCITINIB was reported 269 times

DELGOCITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACETONAEMIC VOMITING 1 0.0556
1 CONJUNCTIVAL PAPILLAE 1 0.0500
2 ATOPIC KERATOCONJUNCTIVITIS 1 0.0286
3 BULLOUS IMPETIGO 1 0.0167
4 MEDIAN NERVE INJURY 1 0.0161
5 CEREBROVASCULAR ARTERIOVENOUS MALFORMATION 1 0.0115
6 ECZEMA HERPETICUM 4 0.0086
7 DERMATOPHYTOSIS OF NAIL 1 0.0084
8 ACQUIRED EPIDERMOLYSIS BULLOSA 1 0.0081
9 ADMINISTRATION SITE IRRITATION 1 0.0071
10 DYSHIDROTIC ECZEMA 5 0.0070
11 GENERALISED PUSTULAR PSORIASIS 2 0.0069
12 OROPHARYNGEAL OEDEMA 1 0.0069
13 NEUROSYPHILIS 1 0.0066
14 HERPES ZOSTER MENINGITIS 1 0.0055
15 APPLICATION SITE HYPOAESTHESIA 1 0.0043
16 HELMINTHIC INFECTION 1 0.0041
17 OCULAR SURFACE DISEASE 1 0.0036
18 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 1 0.0034
19 DEFECT CONDUCTION INTRAVENTRICULAR 1 0.0031
20 APPLICATION SITE OEDEMA 1 0.0031
21 HAND DERMATITIS 2 0.0029
22 TENOPLASTY 1 0.0029
23 HERPES SIMPLEX REACTIVATION 1 0.0026
24 LICHENIFICATION 1 0.0024
25 CUTANEOUS T-CELL LYMPHOMA 3 0.0024
26 ECZEMA NUMMULAR 1 0.0020
27 APPLICATION SITE ACNE 1 0.0020
28 APPLICATION SITE INFECTION 1 0.0020
29 PALMOPLANTAR PUSTULOSIS 1 0.0019
30 MOLLUSCUM CONTAGIOSUM 1 0.0019
31 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
32 NAIL DYSTROPHY 1 0.0018
33 LYMPHOCYTE MORPHOLOGY ABNORMAL 1 0.0017
34 CORNEAL PERFORATION 1 0.0016
35 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
36 CUTANEOUS SYMPTOM 1 0.0015
37 CYCLIC VOMITING SYNDROME 1 0.0014
38 IMPETIGO 2 0.0013
39 DISSEMINATED CRYPTOCOCCOSIS 1 0.0013
40 LYMPHANGITIS 1 0.0012
41 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
42 VULVOVAGINAL ERYTHEMA 1 0.0012
43 FOLLICULAR LYMPHOMA 1 0.0011
44 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
45 ANOGENITAL WARTS 1 0.0011
46 DERMATITIS 21 0.0010
47 BENIGN BREAST NEOPLASM 1 0.0010
48 APPLICATION SITE PAPULES 1 0.0009
49 HYDROCELE 1 0.0009
50 SKIN EROSION 3 0.0009
51 IDIOPATHIC URTICARIA 1 0.0009
52 APPLICATION SITE SCAB 2 0.0009
53 PNEUMONIA STREPTOCOCCAL 1 0.0009
54 ERYTHEMA MULTIFORME 8 0.0009
55 PUSTULE 2 0.0008
56 APPLICATION SITE EROSION 1 0.0008
57 HERPES OPHTHALMIC 1 0.0008
58 MACULAR HOLE 1 0.0007
59 CONJUNCTIVITIS ALLERGIC 1 0.0007
60 PEMPHIGOID 5 0.0007
61 MYELITIS 1 0.0006
62 ONYCHOLYSIS 1 0.0006
63 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
64 ALOPECIA AREATA 1 0.0006
65 MONOPARESIS 1 0.0006
66 DERMATITIS ATOPIC 25 0.0005
67 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
68 CORNEAL DISORDER 1 0.0005
69 VARICELLA 1 0.0004
70 GLOMERULONEPHRITIS 1 0.0004
71 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
72 LUNG OPACITY 1 0.0004
73 STRABISMUS 1 0.0003
74 INJECTION SITE HYPERSENSITIVITY 1 0.0003
75 EOSINOPHILIC PNEUMONIA 1 0.0003
76 HERPES SIMPLEX 2 0.0003
77 HEPATIC CYST 1 0.0003
78 EAR PRURITUS 1 0.0003
79 ERYTHEMA NODOSUM 1 0.0003
80 CONJUNCTIVAL HYPERAEMIA 1 0.0003
81 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
82 TONGUE OEDEMA 1 0.0003
83 SKIN FISSURES 5 0.0003
84 BLEPHARITIS 1 0.0002
85 ECZEMA 13 0.0002
86 APPLICATION SITE DISCOLOURATION 1 0.0002
87 APPLICATION SITE EXFOLIATION 1 0.0002
88 LIP OEDEMA 1 0.0002
89 PRODUCT USE IN UNAPPROVED INDICATION 58 0.0002
90 TENSION HEADACHE 1 0.0002
91 SKIN SWELLING 2 0.0002
92 MONOPLEGIA 1 0.0002
93 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
94 PARONYCHIA 1 0.0002
95 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
96 APPLICATION SITE SWELLING 1 0.0002
97 PRODUCT RESIDUE PRESENT 1 0.0002
98 BURNING SENSATION 13 0.0002
99 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
100 ENTEROCOLITIS 1 0.0002
101 DERMATITIS ACNEIFORM 1 0.0002
102 APPLICATION SITE VESICLES 1 0.0002
103 MENINGITIS 1 0.0001
104 EYE MOVEMENT DISORDER 1 0.0001
105 NEPHROTIC SYNDROME 1 0.0001
106 LARGE INTESTINE POLYP 1 0.0001
107 PAPULE 1 0.0001
108 SKIN BURNING SENSATION 10 0.0001
109 AORTIC ANEURYSM 1 0.0001
110 TRANSPLANT REJECTION 1 0.0001
111 RHINITIS 1 0.0001
112 SKIN EXFOLIATION 10 0.0001
113 SKIN HYPERPIGMENTATION 1 0.0001
114 DRUG ERUPTION 2 0.0001
115 IRON DEFICIENCY ANAEMIA 1 0.0001
116 CONJUNCTIVITIS 2 0.0001
117 APPENDICITIS 1 0.0001
118 HERPES ZOSTER 6 0.0001
119 CELLULITIS 5 0.0001
120 SUBARACHNOID HAEMORRHAGE 1 0.0001
121 DRY SKIN 13 0.0001
122 ERYTHEMA 20 0.0001
123 PETECHIAE 1 0.0001
124 INJECTION SITE NODULE 1 0.0001
125 APPLICATION SITE PAIN 2 0.0001
126 APPLICATION SITE PRURITUS 2 0.0001
127 DERMATITIS CONTACT 1 0.0001
128 SCAB 1 0.0001
129 PRODUCT PRESCRIBING ERROR 2 0.0001
130 RASH ERYTHEMATOUS 4 0.0001
131 LOCALISED INFECTION 2 0.0001
132 TENDON RUPTURE 1 0.0001
133 GENERALISED OEDEMA 1 0.0001
134 INJECTION SITE DISCOLOURATION 1 0.0001
135 PRURITUS 30 0.0001
136 MYDRIASIS 1 0.0001
137 HIATUS HERNIA 1 0.0001
138 INJECTION SITE INDURATION 1 0.0001
139 APPLICATION SITE ERYTHEMA 2 0.0001
140 UVEITIS 1 0.0001
141 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
142 APHONIA 1 0.0001
143 SKIN REACTION 1 0.0001
144 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
145 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
146 IMMUNODEFICIENCY 1 0.0001
147 BACK DISORDER 1 0.0001
148 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
149 FUNGAL INFECTION 2 0.0001
150 CANDIDA INFECTION 1 0.0001
151 GASTROENTERITIS VIRAL 1 0.0001
152 RASH PRURITIC 3 0.0001
153 BACTERIAL INFECTION 1 0.0001
154 PROTEINURIA 1 0.0001
155 INJECTION SITE SWELLING 4 0.0001
156 GLAUCOMA 1 0.0001
157 THERAPEUTIC RESPONSE DECREASED 3 0.0000
158 TOOTH LOSS 1 0.0000
159 RASH PAPULAR 1 0.0000
160 ADVERSE DRUG REACTION 4 0.0000
161 HYPOGLYCAEMIA 2 0.0000
162 RASH 17 0.0000
163 SKIN ULCER 1 0.0000
164 PAIN OF SKIN 1 0.0000
165 PALLOR 1 0.0000
166 BLISTER 2 0.0000
167 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
168 NASAL CONGESTION 2 0.0000
169 LACRIMATION INCREASED 1 0.0000
170 EPILEPSY 1 0.0000
171 ADVERSE EVENT 3 0.0000
172 OROPHARYNGEAL PAIN 3 0.0000
173 LIMB DISCOMFORT 1 0.0000
174 EYE DISORDER 1 0.0000
175 VIRAL INFECTION 1 0.0000
176 NEOPLASM MALIGNANT 2 0.0000
177 EYE PRURITUS 1 0.0000
178 RASH MACULAR 1 0.0000
179 SLEEP DISORDER 2 0.0000
180 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
181 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
182 ACCIDENTAL OVERDOSE 1 0.0000
183 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
184 INJECTION SITE BRUISING 2 0.0000
185 INJECTION SITE ERYTHEMA 3 0.0000
186 URTICARIA 4 0.0000
187 COLITIS ULCERATIVE 1 0.0000
188 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
189 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
190 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
191 VISION BLURRED 3 0.0000
192 SKIN IRRITATION 1 0.0000
193 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
194 SWELLING 2 0.0000
195 INTERSTITIAL LUNG DISEASE 1 0.0000
196 PRODUCT DOSE OMISSION ISSUE 6 0.0000
197 CONDITION AGGRAVATED 6 0.0000
198 INJECTION SITE PAIN 6 0.0000
199 THERAPY CESSATION 1 0.0000
200 INFLAMMATION 1 0.0000
201 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
202 OEDEMA 1 0.0000
203 HAEMATOCHEZIA 1 0.0000
204 MUSCULAR WEAKNESS 2 0.0000
205 URINARY TRACT INFECTION 3 0.0000
206 BLADDER CANCER 1 0.0000
207 CATARACT 1 0.0000
208 DRUG INEFFECTIVE 22 0.0000
209 PLEURAL EFFUSION 1 0.0000
210 RHINORRHOEA 1 0.0000
211 PSORIASIS 2 0.0000
212 FEBRILE NEUTROPENIA 1 0.0000
213 INJECTION SITE PRURITUS 1 0.0000
214 DEVICE MALFUNCTION 1 0.0000
215 HYPOAESTHESIA 2 0.0000
216 ACNE 1 0.0000
217 DIABETES MELLITUS 1 0.0000
218 PERIPHERAL SWELLING 2 0.0000
219 ARTHRITIS 1 0.0000
220 PARAESTHESIA 2 0.0000
221 CARDIAC FAILURE 1 0.0000
222 THROMBOSIS 1 0.0000
223 DRY MOUTH 1 0.0000
224 TREATMENT FAILURE 1 0.0000
225 RENAL IMPAIRMENT 1 0.0000
226 PYREXIA 4 0.0000
227 INTENTIONAL PRODUCT MISUSE 1 0.0000
228 DEVICE ISSUE 1 0.0000
229 ANXIETY 3 0.0000
230 OFF LABEL USE 9 0.0000
231 ATRIAL FIBRILLATION 1 0.0000
232 ILLNESS 1 0.0000
233 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
234 HEADACHE 6 0.0000
235 HAEMORRHAGE 1 0.0000
236 MALAISE 4 0.0000
237 ASTHMA 1 0.0000
238 INCORRECT DOSE ADMINISTERED 2 0.0000
239 CHILLS 1 0.0000
240 OEDEMA PERIPHERAL 1 0.0000
241 VISUAL IMPAIRMENT 1 0.0000
242 DEHYDRATION 1 0.0000
243 INFECTION 1 0.0000
244 CEREBROVASCULAR ACCIDENT 1 0.0000
245 MYALGIA 1 0.0000
246 MYOCARDIAL INFARCTION 1 0.0000
247 COVID-19 1 0.0000
248 NASOPHARYNGITIS 1 0.0000
249 HYPERSENSITIVITY 1 0.0000
250 PAIN 3 0.0000
251 ARTHRALGIA 2 0.0000
252 WEIGHT INCREASED 1 0.0000
253 ABDOMINAL PAIN 1 0.0000
254 DIZZINESS 2 0.0000
255 INSOMNIA 1 0.0000
256 COUGH 1 0.0000
257 DYSPNOEA 2 0.0000
258 DIARRHOEA 2 0.0000
259 FATIGUE 2 0.0000
260 NAUSEA 2 0.0000
261 VOMITING 1 0.0000